Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2020 08:30 ET | Source: Algernon Pharmaceuticals

Algernon Provides an Overview of its NP-120 (Ifenprodil) Program for COVID-19

VANCOUVER, British Columbia, March 24, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
March 23, 2020 08:30 ET | Source: Algernon Pharmaceuticals

Algernon Appoints U.S. Company for cGMP Manufacturing of NP-120 (Ifenprodil) for COVID-19 Clinical Trials

VANCOUVER, British Columbia, March 23, 2020 (GLOBE NEWSWIRE) -- VANCOUVER, BC – (March 23, 2020) – Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
March 20, 2020 14:22 ET | Source: Algernon Pharmaceuticals

Algernon Appoints Novotech as CRO For Phase 2 Coronavirus Ifenprodil Trial

VANCOUVER, British Columbia, March 20, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
March 19, 2020 08:30 ET | Source: Algernon Pharmaceuticals

Algernon to Support Planned Phase 2 Trial of Ifenprodil for Coronavirus

VANCOUVER, British Columbia, March 19, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
March 16, 2020 08:08 ET | Source: Algernon Pharmaceuticals

Algernon entra com pedido de reunião Pre-IND com a FDA dos EUA para Teste de Coronavírus Ifenprodil, Acesso Expandido e Uso de Emergência

VANCOUVER, British Columbia, March 16, 2020 (GLOBE NEWSWIRE) -- A Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (a "Empresa” ou “Algernon”), uma empresa de desenvolvimento...
March 16, 2020 08:08 ET | Source: Algernon Pharmaceuticals

Algernon gibt die Beantragung eines Vorgesprächs mit der US-Arzneimittelbehörde im Hinblick auf die Zulassung von Ifenprodil als Prüfpräparat für eine Coronavirus-Studie, für den erweiterten Zugang sowie für den Einsatz in Härtefällen bekannt

VANCOUVER, British Columbia, March 16, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (das „Unternehmen“ oder „Algernon), ein auf die klinische...
March 16, 2020 08:08 ET | Source: Algernon Pharmaceuticals

Algernon ประกาศยื่นคำขอประชุม Pre-IND ต่อองค์การอาหารและยาแห่งสหรัฐอเมริกาสำหรับการทดลองใช้ การเข้าถึงที่เพิ่มขึ้น และการใช้งานยา Ifenprodil Coronavirus ในกรณีฉุกเฉิน

แวนคูเวอร์, บริติชโคลัมเบีย, March 16, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc.(CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“บริษัท” หรือ “Algernon”)...
March 16, 2020 08:08 ET | Source: Algernon Pharmaceuticals

Algernon Mengumumkan Pemfailan Permintaan Mesyuarat Pra-IND FDA A.S. Untuk Percubaan Coronavirus Ifenprodil, Akses Dikembangkan dan Kegunaan Kecemasan

VANCOUVER, British Columbia, March 16, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“Syarikat” atau “Algernon”) sebuah syarikat pembangunan...
March 16, 2020 08:08 ET | Source: Algernon Pharmaceuticals

アルジェノン、コロナウイルス治療薬としてのイフェンプロジル臨床試験、拡大アクセス、非常時利用について米FDAにIND申請前ミーティング申請を発表

ブリティッシュコロンビア州バンクーバー発, March 16, 2020 (GLOBE NEWSWIRE) -- 臨床病期向け治療薬開発会社のアルジェノン製薬 (Algernon Pharmaceuticals Inc.) (CSE: AGN) (フランクフルト証券取引所: AGW) (OTCQB: AGNPF) (以下「同社」または「アルジェノン」) は、米FDAにIND (臨床試験用新薬)...
March 16, 2020 08:08 ET | Source: Algernon Pharmaceuticals

Algernon Mengajukan Permintaan Rapat Pra-IND dengan Lembaga FDA AS untuk Uji Coba, Perluasan Akses, dan Penggunaan Darurat Ifenprodil Coronavirus

VANCOUVER, British Columbia, March 16, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“Perusahaan” atau “Algernon”), sebuah perusahaan...